Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Dec;25(4):819-34.
doi: 10.1016/j.idc.2011.07.008.

Interferons as therapeutic agents for infectious diseases

Scott J Bergman  1 , McKenzie C Ferguson, Cathy Santanello
Affiliations
Review

Interferons as therapeutic agents for infectious diseases

Scott J Bergman et al. Infect Dis Clin North Am. 2011 Dec.

Abstract

This article explains the rationale for development of interferons as therapeutic agents, and describes commercial products available today. It also provides a summary of studies that have been performed with interferons for use as exogenous biological response modifiers in viral infections. Overall, the best data exist for treatment of viral hepatitis B and C, for which interferons are a cornerstone of therapy. Although infections with human papillomavirus and common cold viruses sometimes respond favorably to interferons, their outcomes are far from ideal. Finally, the role of interferons as vaccine adjuvants is still being explored but could be promising.

PubMed Disclaimer

References

    1. Goering R.V., Dockrell H.M., Zuckerman M. 4th edition. Elsevier Limited; Philadelphia: 2008. Mim’s medical microbiology.
    1. Male D., Brostoff J., Roth D. 7th edition. Elsevier Limited; Philadelphia: 2006. Immunology.
    1. Hayden F.G. Antiviral agents. In: Brunton L.L., Lazo J.S., Parker K.L., editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 11th edition. McGraw-Hill; New York: 2006. pp. 1225–1242.
    1. Mullangi P, Shahani L, Koirala J. Role of endogenous biological response modifiers in pathogenesis of infectious diseases. Infect Dis Clin North Am, in press. - PubMed
    1. Borden E.C., Sen G.C., Uze G. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975–990. - PMC - PubMed

MeSH terms